Description: There are five active Master of Science in Clinical Psychopharmacology (MSCP) Programs that have been approved by the American Psychological Association. Each has a unique training model. The Alliant MSCP program was the first established in the country and has evolved from being an on-ground program with several sites in California, Maryland and Louisiana to being fully online with physical assessment practicum training required for graduation. We have integrated didactic and clinical training so that students actively apply their learning in biochemistry, pathophysiology, neuroscience, pharmacology, psychopharmacology and pharmacotherapeutics. The Psychopharmacology Examination for Psychologists (PEP) exam is required in all jurisdictions that allow appropriately trained psychologists to prescribe. Integration of PEP requirements into MSCP training will be discussed.

CEs: 1.0 CE Available
Program Level: Introductory

Learning Objectives:

• List the five currently active Clinical Psychopharmacology programs that have been approved by APA
• Explain how Clinical Psychopharmacology training contributes to improved patient care and inter-professional communication about patient care
• Discuss cases in which Clinical Psychopharmacology advances the recognition and avoidance of drug-drug interactions
• Recognize how cultural and genomic factors affect successful pharmacotherapeutic outcomes for patients with mental health disorders.
• Distinguish between medical and biopsychosocial approaches to patients receiving pharmacotherapy for comorbid conditions

Speaker: Judi Steinman, Ph.D.